Differences in p16 gene methylation and expression in benign and malignant ovarian tumors

Gynecologic Oncology

Volumn 72, Issue 1, 1999, Pages 87-92

  McCluskey, Lisa L ^a   Chen, Chen ^a   Delgadillo, Erika ^a   Felix, Juan C ^a   Muderspach, Laila I ^a   Dubeau, Louis ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

DNA methylation; Ovarian cancer; P16

Indexed keywords

ARTICLE; BENIGN TUMOR; CYSTADENOMA; DNA METHYLATION; EPITHELIUM TUMOR; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; METHYLATION; OVARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

EID: 0032925917     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5235     Document Type: Article

References (29)

1. Ehrlich M, Wang RY: 5-Methylcytosine in eukaryotic DNA. Science 212:1350-1357, 1981
2. Keshet I, Yisraeli J, Cedar H: Effect of regional DNA methylation on gene expression. Proc Natl Acad Sci USA 82:2560-2564, 1985
3. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 321:209-213, 1986
4. Laird PW, Jaenisch R: DNA methylation and cancer. Hum Mol Genet 3:1487-1495, 1994
5. Spruck CH, Rideout WM, Jones PA: DNA Methylation: Molecular Biology and Biological Significance. Basel, Birkhauser Verlag, 1993
6. Munzel PA, Pfohl LA, Rohrdanz E, Keith G, Dirheimer G, Bock KW: Site-specific hypomethylation of c-myc protooncogene in liver nodules and inhibition of DNA methylation by N-nitrosomorpholine. Biochem Pharmacol 42:365-371, 1991
7. Sharrard RM, Royds JA, Rogers S, Shorthouse AJ: Patterns of methylation of the c-myc gene in human colorectal cancer progression. Br J Cancer 65:667-672, 1992
8. Bhave MR, Wilson MJ, Poirier LA: c-H-ras and c-K-ras gene hypomethylation in the livers and hepatomas of rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis 9:343-348, 1988
9. Ray JS, Harbison ML, McClain RM, Goodman JI: Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse live tumors. Mol Carcinog 9:155-166, 1994
10. Kanada M, Delia D, Aiello A, Stadtmauer E, Reed JC: Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820-1828, 1993
11. Lipsanen V, Leinonen P, Alhonen L, Janne J: Hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia. Blood 72:2042-2044, 1988
12. Felgner J, Kreipe H, Heidorn K, Jaquet K, Zschunke F, Radzun HJ, Parwaresch MR: Increased methylation of the c-fms protooncogene in acute myelomonocytic leukemias. Pathobiology 59:293-298, 1991
13. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger P, Baylin SB, Sidransky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1:686-692, 1995
14. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen TT, Beart RW, Van Tornout JM, Jones PA: Methylation of the 5′ CpG island of the p16/ CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55:4531-4535, 1995
15. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM: Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700-9704, 1994
16. Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP: Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228: 187-190, 1985
17. Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L: Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. Br J Cancer 75:396-402, 1997
18. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in the genesis of many tumor types. Science 264: 436-440, 1994
19. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JPL, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525-4530, 1995
20. Shih YC, Kerr J, Liu J, Hurst T, Khoo SK, Ward B, Wainwright B, Chenevix-Trench G: Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours. Int J Cancer 70:508-511, 1997
21. Shigemasa K, Hu C, West CM, Clarke J, Parham GP, Parmley TH, Korourian S, Baker VV, O'Brien TJ: p16 overexpression: a potential early indicator of transformation in ovarian carcinoma. J Soc Gynecol Invest 4:95-102, 1997
22. Cheng PC, Gosewehr JA, Kim TM, Velicescu MMW, Zheng J, Felix JC, Cofer KF, Luo P, Biela BH, Godorov G, Dubeau L: Potential role of the inactivated X chromosome in ovarian epithelial tumor development. J Natl Cancer Inst 88:510-518, 1996
23. Jarrard DF, Bova GS, Isaacs WB: DNA methylation, molecular genetic and linkage studies in prostate cancer. Prostate Suppl 6:36-44, 1996
24. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826, 1996
25. Dixon WJ, Massey FJ: Introduction to Statistical Analysis. New York, McGraw-Hill, 1969
26. Reed JA, Loganzo F, Shea C, Walker GJ, Flores JF, Glendening JM, Bogdany JK, Shiel MJ, Haluska MG, Fountain JW, Albino AP: Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 55:2713-2718, 1995
27. Ryan A, Al-Jehani RM, Mulligan KT, Jacobs IJ: No evidence exists for methylation inactivation of the p16 tumor suppressor gene in ovarian carcinogenesis. Gynecol Oncol 68:14-17, 1998
28. McCluskey LL, Dubeau L: Biology of ovarian cancer. Curr Opin Oncol 9:465-470, 1997
29. Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Su JQ, Podratz KC, Jenkins RB: Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res 53:4456-4460, 1993